News Daily News Nearly 150 Million US Adults Eligible for CKM Syndrome Meds Caitlin E. Cox February 02, 2026
News Daily News Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors Yael L. Maxwell December 02, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Daily News Getting Ready for a Heart Failure Polypill, Well Before the Data Are In Todd Neale October 16, 2025
News Conference News HFSA 2025 Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74 Yael L. Maxwell September 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2025 Michael O'Riordan September 30, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News European Experts Provide Advice on Managing CV Effects of COVID-19 Todd Neale September 19, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Conference News ESC Heart Failure 2025 Finerenone May Cut Early Readmissions in HF Patients Todd Neale May 21, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Daily News Acoramidis Approved in Europe for ATTR Cardiomyopathy Michael O'Riordan February 12, 2025
Presentation THT 2025 Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR Presenter: Michael Brener February 12, 2025
News Daily News CVD Hospitalization in Older Adults Higher in US Than in Denmark Michael O'Riordan February 07, 2025